PROVIDER PROFILE · NPI 1003991340

Martha Hyde

Internal MedicineSeattle, WAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

371

Beneficiaries

—

Total drug cost

$4K

Distinct drugs

Brand share

3.5%

Top prescribed drugs

Levothyroxine Sodium74 claims

Atorvastatin Calcium69 claims

Amlodipine Besylate39 claims

Losartan Potassium34 claims

Lisinopril33 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Martha Hyde's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 6 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
DYNACARE NORTHWEST, INC	111	467
SWEDISH HEALTH SERVICES	41	70
SWEDISH HEALTH SERVICES	20	31

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
DYNACARE NORTHWEST, INC	153	874
SWEDISH HEALTH SERVICES	60	116
SWEDISH HEALTH SERVICES	25	58
ALBRO, PETER	19	121
Marcus Meyer Ophthalmology · Seattle, WA	11	29
KOVACEVICH, LYNN	11	18

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history